Journal Information
Vol. 38. Issue. 5.September - October 2018
Pages 459-572
Vol. 38. Issue. 5.September - October 2018
Pages 459-572
Editorial
DOI: 10.1016/j.nefroe.2018.10.003
Open Access
Nephrology from a gender perspective
La nefrología desde una perspectiva de género
Visits
900
Maria Dolores Arenas Jiméneza,
Corresponding author
lola@olemiswebs.net

Corresponding author.
, Maria Adoración Martin-Gómezb, Juan Jesús Carreroc, Maria Teresa Ruiz Canterod
a Servicio de Nefrología, Hospital Vithas Perpetuo Internacional, Alicante, Spain
b Servicio de Nefrología, Hospital de Poniente, El Ejido, Almería, Spain
c Departamento de Epidemiología y Bioestadística Médica, Instituto Karolinska, Estocolmo, Sweden
d Departamento de Medicina Preventiva y Salud Pública, Universidad de Alicante, Alicante, Spain
This item has received
900
Visits

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

Approaching medicine from a gender perspective is a relatively recent attempt to identify elements that perpetuate health inequalities between men and women, and considers an opportunity that the two gender may have different experiences and manifestations of the same disease.1 Chronic kidney disease (CKD) shows differences between gender in prevalence and rate of progression, but also in treatment and outcomes, as shown by a recent analysis of DOPPS, which includes data from our country, Spain.2 In the background of these differences are due to biological differences related to the gender and therefore they are not avoidable. But there are also factors related to sociocultural attributes of masculinity and femininity that can be modified to avoid gender inequality in CKD and can serve as areas for improvement. Nephrology, unlike other specialties, has largely ignored this approach, and not many studies investigate scientific evidence of this aspect.3 However “the absence of evidence does not imply evidence of absence”.4,5 The objective of this editorial is to highlight some inequalities or biases in relation to gender in health care, the sex–gender interaction and its influence on kidney disease outcomes. Understanding these differences may help specialists in nephrology to better address the needs of their patients.

Differences between sex and gender inequalities in chronic kidney disease, progression and access to dialysis

CKD shows differences in prevalence according to gender (higher in women),6 evolution (faster progression in men)4,5 and prognosis (young women on dialysis increase their non-cardiovascular mortality and lose the survival advantage over men in general population).2,7

The greater prevalence of CKD in women6 may be due to their longer life expectancy achieving the risk age of CKD, or to inaccuracy of the formulas that estimate the GFR that classify them in a degree of CKD more severe than the real.8

Surprisingly, despite this high prevalence of CKD in women worldwide, in an American study, women constituted the group with greatest risk of late initiation of dialysis, even later than ethnic minorities, the unemployed and patients without health insurance9 and women presented high mortality in predialysis for this reason.10 In the DOPPS study, women started renal replacement therapy (RRT) older and with lower GFR than men.2 The Spanish registry11 shows a higher incidence of men than women in RRT, although we do not have data on mortality separated by gender in this population.

Differences between countries points to a gender bias, with differences in decision-making between men and women – older women opt for conservative treatment rather than dialysis12 – and in primary medical care fewer women than men are diagnosed of CKD, with less referral to nephrology and therefore there is not follow up on renal disease progression.12

Once the RRT is initiated, gender biases in health care are detected. We describe a lower possibility of initiating dialysis through arteriovenous fistula (AVF) in women. In Spain, 20.8% of women are dialyzed with a catheter, 67.7% with AVF and 11.5% with a prosthesis compared to 10.8%, 81.2% and 8% respectively in men.2,13 This disparity is justified by the belief that AVF in women has a worse prognosis than in men,14,15 this could influence the decision of place a catheter vs AVF. However the recently published Spanish Clinical Guide about vascular access for hemodialysis states that female sex is not a risk factor in the prognosis of vascular access.16

Another possible bias that needs to be addressed is the increased risk in women of not receiving optimal dialysis17 because they need more dose of dialysis (KTV>1.6)18 and more dialysis time to improve survival.17 Using the objective of KTV in men (KTV>1.4) in all patients, men and women may favor inequality. It has been reported that women receive less time of dialysis (<12h/week).19

The DOPPS study shows that the sex-gender interaction – more use of catheters and lower dose of dialysis in women – significantly influences the mortality of young women in dialysis, which could justify the loss of survival advantage of women with respect to the general population, despite not being differences in mortality between sexes,2 and even presenting a better survival in women than men in RRT in the Spanish registry,11 and these would be objectives to be considered to improve the results.2

Conversely, women are more likely to be diagnosed of anemia and to receive excess erythropoietin I,20 because physiologically they have less hemoglobin than men and clinical guidelines usually consider a single cut-off point for anemia in both sexes.21

Gender inequalities in kidney transplantation: access to kidney transplantation, organ donation and evolution of the transplant

Women are less likely to receive a corpse transplant,22 which is attributed to higher levels of preformed antibodies; however, women are living donors more frequently than men.23 In Spain, in 2015, 64% of living donors were women and 62% of recipients were male.24 These differences can not be attributed, as in other countries, to gender related psycho-socio-economic factors or the lack of social support networks.25 Differences may be related to differences in gender behavior,26 as well as biological factors – major incidence in men of diseases that require a transplant and a higher prevalence of arteriosclerosis – that may explain less inadequacy as donors.27

It is argued that differences related to gender also influence the results of transplantation: worse prognosis of male recipients attributed to worse adherence and less concern for the graft,28 and some studies attribute a worse survival of the kidneys of donor women to the lower number of nephrons, more HLA antigenic response or greater susceptibility to nephrotoxic.29

In conclusion, the application of the gender perspective improves the scientific rigor and reproducibility of clinical trials, and may provide clues that could lead to new pharmacological targets and treatment strategies. Nephrology is not a leading discipline in this field. In this editorial we have highlighted aspects related to the prevalence, progression and treatment of women and men with CKD, which require further study. A gender perspective in clinical practice will help us to provide better and more personalized care to our patients.

References
[1]
M.T. Ruiz, L.M. Verbrugge.
A two way view of gender bias in medicine.
J Epidemiol Commun Health, 51 (1997), pp. 106-109
[2]
M. Hecking, B.A. Bieber, J. Ethier, A. Kautzky-Willer, G. Sunder-Plassmann, M.D. Säemann, et al.
Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
PLoS Med, 11 (2014), pp. e1001750
[3]
J.J. Carrero.
Gender differences in chronic kidney disease: underpinnings and therapeutic implications.
Kidney Blood Press Res, 33 (2010), pp. 383-392
[4]
G. Cobo, M. Hecking, F.K. Port, I. Exner, B. Lindholm, P. Stenvinkel, et al.
Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis.
Clin Sci (Lond), 130 (2016), pp. 1147-1163
[5]
J.J. Carrero, M. Hecking, N.C. Chesnaye, K.J. Jager.
Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.
Nat Rev Nephrol, 14 (2018), pp. 151-164
[6]
N.R. Hill, S.T. Fatoba, J.L. Oke, J.A. Hirst, C.A. O’Callaghan, D.S. Lasserson, et al.
Global prevalence of chronic kidney disease – a systematic review and meta-analysis.
PLoS ONE, 11 (2016), pp. e0158765
[7]
J.J. Carrero, D.J. de Jager, M. Verduijn, P. Ravani, J. de Meester, J.G. Heaf, et al.
Cardiovascular and noncardiovascular mortality among men and women starting dialysis.
Clin J Am Soc Nephrol, 6 (2011), pp. 1722-1730
[8]
F. Simal, J.C. Martín Escudero, J. Bellido, D. Arzua, F.J. Mena, I. González Melgosa, et al.
Prevalence of mild to moderate chronic kidney disease in the general population of Spain, Hortega study.
Nefrologia, 24 (2004), pp. 329-337
[9]
E. Streja, S.B. Nicholas, K.C. Norris.
Controversies in timing of dialysis initiation and the role of race and demographics.
Semin Dial, 26 (2013), pp. 658-666
[10]
D. Nitsch, M. Grams, Y. Sang, C. Black, M. Cirillo, O. Djurdjev, et al.
Chronic kidney disease prognosis consortium associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.
BMJ, 346 (2013), pp. f324
[11]
Registro de diálisis y trasplante 2016. Available from: www.senefro.org [accessed 21.2.18].
[12]
C. Sparke, L. Moon, F. Green, T. Mathew, A. Cass, S. Chadban, et al.
Estimating the total incidence of kidney failure in Australia including individuals who are not treated by dialysis or transplantation.
Am J Kidney Dis, 61 (2013), pp. 413-419
[13]
M. Markell, A. Brar, D.G. Stefanov, M.O. Salifu.
Gender disparity in fistula use at initiation of hemodialysis varies markedly across ESRD networks – analysis of USRDS data.
Hemodial Int, 22 (2018), pp. 168-175
[14]
W.C. Jennings, A. Mallios, N. Mushtaq.
Proximal radial artery arteriovenous fistula for hemodialysis vascular access.
J Vasc Surg, 67 (2018), pp. 244-253
[15]
J. Almasri, M. Alsawas, M. Mainou, R.A. Mustafa, Z. Wang, K. Woo, et al.
Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis.
J Vasc Surg, 64 (2016), pp. 236-243
[16]
J. Ibeas, R. Roca-Tey, J. Vallespín, T. Moreno, G. Moñux, et al.
Guía clínica española del acceso vascular para hemodiálisis.
Nefrología, 37 (2017), pp. 1-177
[17]
J.E. Miller, C.P. Kovesdy, A.R. Nissenson, R. Mehrotra, E. Streja, D. van Wyck, et al.
Association of hemodialysis treatment time and dose with mortality and the role of race and sex.
Am J Kidney Dis, 55 (2010), pp. 100-112
[18]
G. Eknoyan, G. Beck, A.K. Cheung, J.T. Daugirdas, T. Greene, J. Kusek, Hemodialysis (HEMO) Study Group, et al.
Effect of dialysis dose and membrane flux in maintenance hemodialysis.
N Engl J Med, 347 (2003), pp. 2010-2019
[19]
C. Couchoud, J. Kooman, P. Finne, T. Leivestad, O. Stojceva-Taneva, J.B. Ponikvar, QUality European STudies Working Group on Dialysis Adequacy, et al.
From registry data collection to international comparisons: examples of haemodialysis duration and frequency.
Nephrol Dial Transplant, 24 (2009), pp. 217-224
[20]
O. Ifudu, J. Uribarri, I. Rajwani, V. Vlacich, K. Reydel, G. Delosreyes, et al.
Gender modulates responsiveness to recombinant erythropoietin.
Am J Kidney Dis, 38 (2001), pp. 518-522
[21]
F. Locatelli, A.R. Nissenson, B.J. Barrett, R.G. Walker, D.C. Wheeler, K.U. Eckardt, et al.
Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
Kidney Int, 74 (2008), pp. 1237-1240
[22]
J.J. Carrero, M. Hecking, I. Ulasi, L. Sola, B. Thomas.
Chronic kidney disease, gender, and access to care: a global perspective.
Semin Nephrol, 37 (2017), pp. 296-308
[23]
J.L. Steinman.
Gender disparity in organ donation.
Gender Med, 3 (2006), pp. 246-252
[24]
Memoria de trasplante renal de ONT. Available from: www.ont.es [accessed 21.2.18].
[25]
R.M. Jindal, J.J. Ryan, I. Sajjad, M.H. Murthy, L.S. Baines.
Kidney transplantation and gender disparity.
Am J Nephrol, 25 (2005), pp. 474-483
[26]
M.J. Legato.
Gender-specific issues in organ transplantation.
Principles of gender-specific medicine, 1st ed.,
[27]
F. Puoti, A. Ricci, A. Nanni-Costa, W. Ricciardi, W. Malorni, E. Ortona.
Organ transplantation and gender differences: a paradigmatic example of intertwining between biological and sociocultural determinants.
Biol Sex Differ, 7 (2016), pp. 35
[28]
J. Rosenberger, A.M. Geckova, J.P. van Dijk, Y. Nagyova, R. Roland, W.J. van den Heuvel, et al.
Prevalence and characteristics of noncompliant behaviour and its risk factors in kidney transplant recipients.
Transplant Int, 18 (2005), pp. 1072-1078
[29]
R. Auglienė, E. Dalinkevičienė, V. Kuzminskis, M. Jievaltas, L. Peleckaitė, A. Gryguc, et al.
Factors influencing renal graft survival: 7-year experience of a single center.
Medicine (Kaunas), 53 (2017), pp. 224-232

Please cite this article as: Arenas Jiménez MD, Martin-Gómez MA, Carrero JJ, Ruiz Cantero MT. La nefrología desde una perspectiva de género. Nefrologia. 2018;38:463–465.

Copyright © 2018. Sociedad Española de Nefrología
Idiomas
Nefrología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.